Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: Trans-PtL(NH 3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-α)pyridine

Journal of Inorganic Biochemistry

Volumn 98, Issue 8, 2004, Pages 1261-1270

  Huq, Fazlul ^a   Qing Yu, Jun ^a   Daghriri, Hassan ^a   Beale, Philip ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Anticancer drugs; Cell culture; Gel electrophoresis; Hydroxypyridine; Planaramine; Transplatinum

Indexed keywords

2 HYDROXYPYRIDINE(AMINO)DICHLOROPLATINUM; 3 HYDROXYPYRIDINE(AMINO)DICHLOROPLATINUM; CISPLATIN; IMIDAZO[1,2 A]PYRIDINE(AMINO)DICHLOROPLATINUM; IMIDAZOLE(AMINO)DICHLOROPLATINUM; NUCLEIC ACID BASE; PLASMID DNA; PLATINUM COMPLEX; TRANSPLATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA CONFORMATION; DRUG DNA BINDING; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DNA; HUMANS; IMIDAZOLES; LIGANDS; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; ORGANOPLATINUM COMPOUNDS; PYRIDINES;

EID: 3242656426     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2004.05.014     Document Type: Article

References (43)

1. Pinedo H.M., Schornagel J.H. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. 1996;Plenum Press, New York
2. Loehrer P.J., Einhorn L.H. Ann. Int. Med. 100:1984;704-713
3. Dorr R.T., Fritz W.L. Cancer Chemotherapy Handbook. 1980;Kimpton, London
4. Calvert A.H., Newell D.R., Tilby M.J. Oxford Textbook of Oncology 2 v. (xxiii, 2481, 2124). 1995;Oxford University Press, Oxford, New York
5. Daugaard G., Abildgaard U. Cancer Chemother. Pharmacol. 25:1989;1-9
6. Moroso M.J., Blair R.L. J. Otolaryngol. 12:1983;365-369
7. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., Finn A.L. N. Engl. J. Med. 322:1990;810-816
8. Kartalou M., Essigmann J.M. Mut. Res. 478:2001;1-21
9. Levi F., Perpoint B., Garufi C., Focan C., Chollet P., Depres-Brummer P., Zidani R., Brienza S., Itzhaki M., Iacobelli S. Eur. J. Cancer. 29A:1993;1280-1284
10. Boccarelli A., Coluccia M., Intini F.P., Natile G., Locker D., Leng M. Anti-Cancer Drug Design. 14:1999;253-264
11. Gelasco A., Lippard S. Metallopharmaceuticals I: DNA Interactions. 1999;Springer, Berlin, London. 3-43
12. Kelland L.R., McKeage M.J. Drugs & Aging. 5:1994;85-95
13. Farrell N., Ha T.T., Souchard J.P., Wimmer F.L., Cros S., Johnson N.P. J. Med. Chem. 32:1989;2240-2241
14. Farrell N., Kelland L.R., Roberts J.D., Van Beusichem M. Cancer Res. 52:1992;5065-5072
15. Farrell N. Met. Ions Biol. Syst. 32:1996;603-639
16. Farrell N., Qu Y., Roberts J.D. Topics in Biological Inorganic Chemistry. 1:1999;Springer, Berlin ; London. 99-115
17. Mellish K.J., Barnard C.F., Murrer B.A., Kelland L.R. Int. J. Cancer. 62:1995;717-723
18. Van Beusichem M., Farrell N. Inorg. Chem. 31:1992;634-639
19. Zou Y., Van Houten B., Farrell N. Biochemistry. 32:1993;9632-9638
20. Natile G., Couluccia M. Metallopharmaceuticals I: DNA Interactions. 1999;Springer, Berlin ; London. pp. 73-98
21. Kasparkova J., Marini V., Najajreh Y., Gibson D., Brabec V. Biochemistry. 42:2003;6321-6332
22. Natile G., Coluccia M. Coord. Chem. Rev. 216:2001;383-410
23. F. Huq, J.Q. Yu, H. Daghriri, P. Beale, K. Fisher, Eur. J. Med. Chem, 30 April 2004, accepted
24. Kauffman G., Cowan D. Inorg. Synth. 7:1963;239-245
25. Stellwagen N. Nucleic Acid Electrophoresis. 1998;Springer, Berlin, New York. pp. 1-53
26. Roberts R.J., Wilson G.A., Young F.E. Nature. 265:1977;82-84
27. Sutcliffe J.G. Cold Spring Harbor Symp. Quant. Biol. 43:1979;77-90
28. Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique. 1994;Wiley-Liss, New York
29. Mosmann T., Immunol J. Methods. 65:1983;55-63
30. Di Blasi P., Bernareggi A., Beggiolin G., Piazzoni L., Menta E., Formento M.L. Anticancer Res. 18:1998;3113-3117
31. Roberts J.D., Peroutka J., Farrell N. J. Inorg. Biochem. 77:1999;51-57
32. Bowtell D.D. Anal. Biochem. 162:1987;463-465
33. Eastman A., Jennerwein M.M., Nagel D.L. Chem.-Biol. Interact. 67:1988;71-80
34. Bernalmendez E., Boudvillain M., Gonzalezvilchez F., Leng M. Biochemistry. 36:1997;7281-7287
35. Eastman A., Barry M.A. Biochemistry. 26:1987;3303-3307
36. Kasparkova J., Novakova O., Marini V., Najajreh Y., Gibson D., Perez J.M., Brabec V. J. Biol. Chem. 278:2003;47516-47525
37. Paquet F., Boudvillain M., Lancelot G., Leng M. Nucleic Acids Res. 27:1999;4261-4268
38. Lippert B. Prog. Inorg. Chem. 37:1989;1-97
39. Sherman S.E., Gibson D., Wang A.H.J., Lippard S.J. J. Am. Chem. Soc. 110:1988;7368-7381
40. Johnson S.W., Ozols R.F., Hamilton T.C. Cancer. 71:1993;644-649
41. Epstein R.J. J. Clin. Oncol. 8:1990;2062-2084
42. Bates S., Vousden K.H. Curr. Opin. Gen. Dev. 6:1996;12-18
43. Anthoney D.A., McIlwrath A.J., Gallagher W.M., Edlin A.R., Brown R. Cancer Res. 56:1996;1374-1381